These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21266721)

  • 21. Diagnostic pathology for the cancer patient.
    Newman SJ
    Clin Tech Small Anim Pract; 2003 May; 18(2):139-44. PubMed ID: 12831079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic markers for myeloid neoplasms: a comparative review of the literature and goals for future investigation.
    Juopperi TA; Bienzle D; Bernreuter DC; Vernau W; Thrall MA; McManus PM
    Vet Pathol; 2011 Jan; 48(1):182-97. PubMed ID: 21139142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The search for suitable prognostic markers for canine mammary tumors: A promising outlook.
    Zaidan Dagli ML
    Vet J; 2008 Jul; 177(1):3-5. PubMed ID: 18054505
    [No Abstract]   [Full Text] [Related]  

  • 24. Expression of cyclooxygenase-2 in canine uveal melanocytic neoplasms.
    Paglia D; Dubielzig RR; Kado-Fong HK; Maggs DJ
    Am J Vet Res; 2009 Oct; 70(10):1284-90. PubMed ID: 19795944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases.
    von Euler H; Eriksson S
    Vet Comp Oncol; 2011 Mar; 9(1):1-15. PubMed ID: 21303450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canine subcutaneous mast cell tumors: cellular proliferation and KIT expression as prognostic indices.
    Thompson JJ; Yager JA; Best SJ; Pearl DL; Coomber BL; Torres RN; Kiupel M; Foster RA
    Vet Pathol; 2011 Jan; 48(1):169-81. PubMed ID: 21160022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal cell carcinoma: current prognostic factors. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).
    Gelb AB
    Cancer; 1997 Sep; 80(5):981-6. PubMed ID: 9307202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Report of the Colorectal Cancer Working Group.
    Fielding LP; Pettigrew N
    Arch Pathol Lab Med; 1995 Dec; 119(12):1115-21. PubMed ID: 7503659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of intratumoral microvessel density in canine soft-tissue sarcomas.
    Luong RH; Baer KE; Craft DM; Ettinger SN; Scase TJ; Bergman PJ
    Vet Pathol; 2006 Sep; 43(5):622-31. PubMed ID: 16966439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canine gastrointestinal stromal tumors: immunohistochemical expression of CD34 and examination of prognostic indicators including proliferation markers Ki67 and AgNOR.
    Gillespie V; Baer K; Farrelly J; Craft D; Luong R
    Vet Pathol; 2011 Jan; 48(1):283-91. PubMed ID: 20826846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canine balloon and signet-ring cell melanomas: a histological and immunohistochemical characterization.
    Cangul IT; van Garderen E; van der Linde-Sipman JS; van den Ingh TS; Schalken JA
    J Comp Pathol; 2001; 125(2-3):166-73. PubMed ID: 11578133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemistry in melanocytic proliferative lesions.
    de Wit NJ; van Muijen GN; Ruiter DJ
    Histopathology; 2004 Jun; 44(6):517-41. PubMed ID: 15186267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canine limbal melanoma: 30 cases (1992-2004). Part 2. Treatment with lamellar resection and adjunctive strontium-90beta plesiotherapy--efficacy and morbidity.
    Donaldson D; Sansom J; Adams V
    Vet Ophthalmol; 2006; 9(3):179-85. PubMed ID: 16634932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication.
    Webster JD; Yuzbasiyan-Gurkan V; Miller RA; Kaneene JB; Kiupel M
    Vet Pathol; 2007 May; 44(3):298-308. PubMed ID: 17491070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of heat shock protein 105 in melanoma and melanocytic naevi.
    Muchemwa FC; Nakatsura T; Fukushima S; Nishimura Y; Kageshita T; Ihn H
    Melanoma Res; 2008 Jun; 18(3):166-71. PubMed ID: 18477890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulation of the Wnt/beta-catenin signaling pathway in canine cutaneous melanotic tumor.
    Han JI; Kim DY; Na KJ
    Vet Pathol; 2010 Mar; 47(2):285-91. PubMed ID: 20139375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 expression and apoptosis in melanomas of dogs and cats.
    Roels S; Tilmant K; Ducatelle R
    Res Vet Sci; 2001 Feb; 70(1):19-25. PubMed ID: 11170847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
    Nazarian RM; Prieto VG; Elder DE; Duncan LM
    J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving the diagnosis and treatment of canine mammary tumours: Immunohistochemical markers as prognostic tools.
    Morris JS
    Vet J; 2010 Apr; 184(1):3-4. PubMed ID: 19713137
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.